Clinic Logo

Discover the Root Causes Comprehensive Cancer Panel

Early Detection. Genetic Insights. Personalized Prevention

Our advanced cancer testing combines cutting-edge blood-based and genetic tools to provide a proactive approach to early detection and personalized cancer risk management.

Key Features

Empowering Personalized Cancer Prevention Through Advanced Testing

Our comprehensive cancer testing panel provides a complete overview of cancer risk, integrating early detection and hereditary insights. Each component plays a crucial role in proactive healthcare management.

Multi-Cancer Early Detection testing

Multi-Cancer Early Detection (MCED)

Galleri® Test (by GRAIL)

  • bullet A blood test that uses methylation patterns to detect signals associated with >50 types of cancer.
  • bullet Intended for adults 50+ years or those at elevated risk.
  • bullet Provides a “cancer signal detected / not detected” result, with tissue of origin prediction.
  • bullet FSA/HSA Eligible
Genetic testing for cancer risk

Genetic Testing for Cancer Risk

Hereditary Cancer Panels

  • bullet Panels typically test 30–80 genes associated with hereditary cancer risk (BRCA1/2, TP53, Lynch syndrome genes, etc.).
  • bullet Identify individuals with a significantly elevated lifetime cancer risk.
  • bullet Testing can guide personalized screening (e.g., earlier colonoscopies, breast MRI).
  • bullet One-time test usually not repeated unless new panels are indicated.
Standard tumor markers testing

Standard Tumor Markers (used selectively, not for population screening)

  • bullet PSA (prostate), CA-125 (ovarian), CEA, AFP, CA 19-9.
  • bullet Use only for high-risk groups or symptom evaluation.